Keywords: Contract manufacturing, CMOs, Frost & Sullivan, Outsourcing

Rising interest of Big Pharma creates huge growth potential for outsourcing firms, says Frost & Sullivan

Article | 24 January 2012

Increasingly, big pharma is viewing the outsourcing of pharmaceutical manufacturing as a strategic move that would enable them to focus ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in